S1004-11
/ Houston Methodist Research Institute
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 14, 2023
A humanized therapeutic antibody against S100A4 as a novel immune modulator and an inhibitor of cancer metastasis
(AACR 2023)
- "These findings strongly suggest that S100A4-11 could be used to block metastasis. We are currently testing the humanized S1004-11 antibody in preparation for clinical studies with this novel immune modulator."
Brain Cancer • Breast Cancer • CNS Tumor • Glioma • Oncology • Solid Tumor • CD163 • CD4 • ITGAM • S100A4
1 to 1
Of
1
Go to page
1